Metabolomics analysis of multidrug-resistant breast cancer cellsin vitrousing methyl-tert-butyl ether method
Author:
Affiliation:
1. National Center of Mass Spectrometry in Changchun
2. Jilin Province Key Laboratory of Chinese Medicine Chemistry and Mass Spectrometry
3. Changchun Institute of Applied Chemistry
4. Chinese Academy of Sciences
5. Changchun 130022
Abstract
MTBE-based cellular lipidomics to investigate the mechanisms of multidrug resistance of breast cancer.
Funder
National Natural Science Foundation of China
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2018/RA/C7RA12952A
Reference42 articles.
1. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
2. Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulation
3. A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues
4. Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography–mass spectrometry
5. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Screening of postoperative adjuvant chemotherapy-related serum metabolic markers in breast cancer patients based on 1H NMR metabonomics;Translational Cancer Research;2024-06
2. Adverse effect of Tamarindus indica and tamoxifen combination on redox balance and genotoxicity of breast cancer cell;Journal of Genetic Engineering and Biotechnology;2023-12
3. Inhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer;Molecules;2022-02-14
4. Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance;EBioMedicine;2021-04
5. Metabolomic profiling of pancreatic adenocarcinoma reveals fundamental clinical features;2021-02-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3